EIRGEN PHARMA LTD.
13Patents
13Active
13Granted
48Portfolio score
Filing activity: Apr 25, 2008 → Oct 11, 2021 · 2 expiring within 5 years
Most-cited patents
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US11000480B2 | Pediatric dosage forms, methods of making and using | Human Necessities | 3 | Active |
| US11173168B2 | Methods of treating vitamin D insufficiency in chronic kidney disease | Human Necessities | 1 | Active |
| US11007205B2 | Adjunctive therapy with 25-hydroxyvitamin D and articles therefor | Chemistry; Metallurgy | 1 | Active |
| US11672809B2 | Methods and compositions for reducing parathyroid levels | Human Necessities | 0 | Active |
| US11926583B2 | Stabilized 1, 25-dihydroxyvitamin D2 and method of making same | Human Necessities | 0 | Active |
| US11752158B2 | Method of treating vitamin D insufficiency and deficiency | Human Necessities | 0 | Active |
| US12208106B2 | Methods of vitamin D treatment | Human Necessities | 0 | Active |
| US11452734B2 | Method of treating and preventing secondary hyperparathyroidism | Human Necessities | 0 | Active |
| US11590148B2 | Use of calcifediol in bariatric surgery patients | Human Necessities | 0 | Active |
| US11738033B2 | Adjunctive therapy with 25-hydroxyvitamin D and articles therefor | Chemistry; Metallurgy | 0 | Active |
| US11154509B2 | Methods for controlled release oral dosage of a vitamin D compound | Human Necessities | 0 | Active |
| US11253528B2 | Stabilized modified release Vitamin D formulation and method of administering same | Human Necessities | 0 | Active |
| US12133917B2 | Pediatric dosage forms, methods of making and using | Human Necessities | 0 | Active |
Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.